Park JH - Search Results

1

Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.

Lee KW, Kim JH, Park JH, Kim HP, Song SH, Kim SG, Kim TY, Jong HS, Jung KH, Im SA, Kim TY, Kim NK, Bang YJ. Lee KW, et al. Among authors: park jh. Anticancer Res. 2006 Sep-Oct;26(5A):3429-38. Anticancer Res. 2006. PMID: 17094463 Free article.

2

Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells.

Park JH, Kim TY, Jong HS, Kim TY, Chun YS, Park JW, Lee CT, Jung HC, Kim NK, Bang YJ. Park JH, et al. Among authors: park jw. Clin Cancer Res. 2003 Jan;9(1):433-40. Clin Cancer Res. 2003. PMID: 12538497

3

A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells.

Choi HH, Jong HS, Park JH, Choi S, Lee JW, Kim TY, Otsuki T, Namba M, Bang YJ. Choi HH, et al. Among authors: park jh. Int J Oncol. 2003 Oct;23(4):1087-93. Int J Oncol. 2003. PMID: 12963989

4

Synthesis and biological evaluation of 3-(4-substituted-phenyl)-N-hydroxy-2-propenamides, a new class of histone deacetylase inhibitors.

Kim DK, Lee JY, Kim JS, Ryu JH, Choi JY, Lee JW, Im GJ, Kim TK, Seo JW, Park HJ, Yoo J, Park JH, Kim TY, Bang YJ. Kim DK, et al. Among authors: park jh, park hj. J Med Chem. 2003 Dec 18;46(26):5745-51. doi: 10.1021/jm030377q. J Med Chem. 2003. PMID: 14667227

5

Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation.

Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Kim TY, Bang YJ. Park JH, et al. Clin Cancer Res. 2004 Aug 1;10(15):5271-81. doi: 10.1158/1078-0432.CCR-03-0709. Clin Cancer Res. 2004. PMID: 15297431

6

The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.

Kim SG, Kim HA, Jong HS, Park JH, Kim NK, Hong SH, Kim TY, Bang YJ. Kim SG, et al. Among authors: park jh. Mol Biol Cell. 2005 Oct;16(10):4672-83. doi: 10.1091/mbc.e05-01-0054. Epub 2005 Aug 10. Mol Biol Cell. 2005. PMID: 16093355 Free PMC article.

7

Histone deacetylase inhibitor enhances 5-fluorouracil cytotoxicity by down-regulating thymidylate synthase in human cancer cells.

Lee JH, Park JH, Jung Y, Kim JH, Jong HS, Kim TY, Bang YJ. Lee JH, et al. Among authors: park jh. Mol Cancer Ther. 2006 Dec;5(12):3085-95. doi: 10.1158/1535-7163.MCT-06-0419. Mol Cancer Ther. 2006. PMID: 17172411

8

Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression.

Kim SH, Park J, Choi MC, Kim HP, Park JH, Jung Y, Lee JH, Oh DY, Im SA, Bang YJ, Kim TY. Kim SH, et al. Among authors: park jh, park j. Biochem Biophys Res Commun. 2007 Apr 6;355(2):318-23. doi: 10.1016/j.bbrc.2007.01.187. Epub 2007 Feb 8. Biochem Biophys Res Commun. 2007. PMID: 17303076

9

Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy.

Jung Y, Park J, Kim TY, Park JH, Jong HS, Im SA, Robertson KD, Bang YJ, Kim TY. Jung Y, et al. Among authors: park jh, park j. J Mol Med (Berl). 2007 Oct;85(10):1137-48. doi: 10.1007/s00109-007-0216-z. Epub 2007 Jun 15. J Mol Med (Berl). 2007. PMID: 17571247

10

Inhibitors of histone deacetylases induce tumor-selective cytotoxicity through modulating Aurora-A kinase.

Park JH, Jong HS, Kim SG, Jung Y, Lee KW, Lee JH, Kim DK, Bang YJ, Kim TY. Park JH, et al. J Mol Med (Berl). 2008 Jan;86(1):117-28. doi: 10.1007/s00109-007-0260-8. Epub 2007 Sep 13. J Mol Med (Berl). 2008. PMID: 17851643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,389 results

Search Page

Filters